Implementation and evaluation of a Pharmacist-Assisted Warfarin Dosing Program

Canadian Journal of Hospital Pharmacy

Volumn 50, Issue 4, 1997, Pages 169-175

  To, Eliza K ^a,e   Pearson, Glen J ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Anticoagulation; Dosing; Guidelines; Prescribing; Program; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHARMACIST; PRACTICE GUIDELINE;

EID: 0030773995     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Copeland GP, Apgar DA. The pharmacist practitioner training program. Drug Intell Clin Pharm 1980;14:114-9.
2. Covington, TR. Toward rational approach to the issue of prescribing authority for pharmacists. Drug Intell Clin Pharm 1983;17:660-6.
3. Martin JK, Norwood MB. Pharmacist management of antiemetic therapy under protocol in an oncology clinic. Am J Hosp Pharm 1988;45:1322-8.
4. Fennerty A, Dolben J, Thomas P, et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J 1984;228:1268-70.
5. Holford, NHG. Clinical pharmacokinetics and pharmacodynamics of warfarin - understanding the dose - effect relationship. Clin Pharmacokin 1986;11:483-504.
6. Shetty HGM, Fennerty AG, Routledge PA. Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokin 1989;16:238-53.
7. Glynn MFX, The Department of Pharmacy Services. Anticoagulation guidelines: warfarin therapy. The Toronto Hospital Formulary. Toronto: The Toronto Hospital; 1996:224-5.
8. Hirsh J, Dalen JE, Deykin JE, et al. Oral Anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1992;102 (Suppl 4): 312S-26S.
9. Anonymous. Chapter 8: Principles of oral anticoagulant drug interactions. In: Hansten PD, Horn JR, eds. Drug Interactions, and Updates. Philadelphia: Lea & Febiger, 1993:57-61.
10. Buckely NA, Dawson AH. Drug Interactions with warfarin. Med J Aust 1992;157:479-83.
11. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 1993;95:315-27.
12. Brigden M. Oral anticoagulant therapy - New indications and an improved method of monitoring. Postgrad Med 1992;91:285-96.
13. Turpie AGG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement. N Engl J Med 1993;329:524-9.
14. Rivey MP, Wood RD, Allington DR, et al. Pharmacy-managed protocol for warfarin use in orthopedic surgery patients. Am J Health-Syst Pharm 1995;52:1310-6.
15. Anonymous. Statutes of Ontario - Chapter 18. In: Regulated Health Professions Act,Toronto: The Queen's Printer for Ontario, 1994:9.